As a synthetic compound, Sculptra is injected into the body where it progressively thickens the skin. The fat is replaced by volume so that the loss of fat is no longer noticeable. Since Sculptra is composed entirely of poly-L-lactic acid which is a synthetic material no skin test is required for use in patients. The elimination of the testing process ensures Sculptra as a more efficient form of treatment. Used internationally since 1999, Sculptra has helped an estimated 150,000 patients in over 30 countries. The treatment became widespread due to its consistent and lasting results. In May 2002 Dermik Laboratories, a United States company, acquired Sculptra and since then it has become a popular method for treating Lipoatrophy in this country. The FDA approved Sculptra in the United States on August 3, 2004.Request a Consultation
A world-renowned landmark located in San Diego County, Goldman, Butterwick, Fitzpatrick, & Groff, Cosmetic Laser Dermatology brings together scientific breakthroughs in the aesthetic industry and the art of vision, creativity and skill. In a warm, social environment of approachable luxury, GBFG brings patients the best in rejuvenation and the highest quality of personal attention.
Mitchel GoldmanDouble-board certified dermatologist and cosmetic surgeon, Dr. Mitchel Goldman M.D. is the founder and Medical Director of Goldman Butterwick & Associates, Cosmetic Laser Dermatology. After graduating Boston University and Stanford University Medical School, Dr. Goldman has pioneered research on multiple laser techniques, skin rejuvenation, and vein therapy. Dr. Goldman is the Director of the American Academy of Cosmetic Surgery Dermatologic Surgery Fellowship Program and has practice/hospital affiliations with Scripps Memorial Hospital in La Jolla, California.